- Home
- ARWR vs KNTK Comparison
ARWR vs KNTK Comparison
Compare ARWR & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- KNTK
- Stock Information
- Founded
- ARWR 2003
- KNTK 2017
- Country
- ARWR United States
- KNTK United States
- Employees
- ARWR N/A
- KNTK N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- KNTK Natural Gas Distribution
- Sector
- ARWR Health Care
- KNTK Utilities
- Exchange
- ARWR Nasdaq
- KNTK Nasdaq
- Market Cap
- ARWR 2.5B
- KNTK 2.8B
- IPO Year
- ARWR 1993
- KNTK N/A
- Fundamental
- Price
- ARWR $36.64
- KNTK $38.76
- Analyst Decision
- ARWR Strong Buy
- KNTK Buy
- Analyst Count
- ARWR 8
- KNTK 9
- Target Price
- ARWR $47.75
- KNTK $54.33
- AVG Volume (30 Days)
- ARWR 2.4M
- KNTK 1.3M
- Earning Date
- ARWR 11-25-2025
- KNTK 11-05-2025
- Dividend Yield
- ARWR N/A
- KNTK 8.13%
- EPS Growth
- ARWR N/A
- KNTK N/A
- EPS
- ARWR N/A
- KNTK 0.73
- Revenue
- ARWR $572,976,000.00
- KNTK $1,652,079,000.00
- Revenue This Year
- ARWR $21,421.26
- KNTK $30.22
- Revenue Next Year
- ARWR N/A
- KNTK $14.45
- P/E Ratio
- ARWR N/A
- KNTK $52.33
- Revenue Growth
- ARWR 2816.20
- KNTK 19.71
- 52 Week Low
- ARWR $9.57
- KNTK $37.75
- 52 Week High
- ARWR $39.42
- KNTK $67.60
- Technical
- Relative Strength Index (RSI)
- ARWR 73.44
- KNTK 36.67
- Support Level
- ARWR $36.29
- KNTK $38.21
- Resistance Level
- ARWR $39.38
- KNTK $46.63
- Average True Range (ATR)
- ARWR 1.39
- KNTK 1.72
- MACD
- ARWR 0.06
- KNTK -0.68
- Stochastic Oscillator
- ARWR 69.44
- KNTK 5.88
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About KNTK Kinetik Holdings Inc.
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.